Milind Misra

dblp:69/48 · DBLP profile ↗
← Back
3ranked-venue papers
2as first author
1since 2021 · last 2024
—ORCID · none

Domains — the database's venue-derived domains; a paper can count in several

Applied, interdisciplinary, general and emerging computing · 3 · 2 first-author · 1 since 2021

Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.

Interdisciplinary, comprehensive, and emerging computing
3 papers
Bioinformatics and computational biology · 100%

Topics — the 3 heaviest of 4, each with the papers that count most for it

TopicWeightPapersLastEvidence papers
Bioinformatics and computational biology › microbiology
virology
0.822024
HIResist: a database of HIV-1 resistance to broadly neutralizing antibodies · Bioinform. 2024
Flavitrack: an annotated database of flavivirus sequences · Bioinform. 2007
Bioinformatics and computational biology › drug discovery
drug-target interaction
0.112008
Genome scale enzyme-metabolite and drug-target interaction predictions using the signature molecular descriptor · Bioinform. 2008
Bioinformatics and computational biology › drug discovery
drug-target interaction prediction
0.112008
Genome scale enzyme-metabolite and drug-target interaction predictions using the signature molecular descriptor · Bioinform. 2008

Methods — techniques the papers use, named apart from their topics

cross-sensitivity visualization · 0.8bioinformatic sequence pattern analysis · 0.8signature molecular descriptor · 0.1machine learning · 0.1sequence annotation · 0.1phylogenetic relationship analysis · 0.1
YearPublicationVenuePosition
2024 HIResist: a database of HIV-1 resistance to broadly neutralizing antibodies
abstract
MOTIVATION: Changing the course of the human immunodeficiency virus type I (HIV-1) pandemic is a high public health priority with approximately 39 million people currently living with HIV-1 (PLWH) and about 1.5 million new infections annually worldwide. Broadly neutralizing antibodies (bnAbs) typically target highly conserved sites on the HIV-1 envelope glycoproteins (Envs), which mediate viral entry, and block the infection of diverse HIV-1 strains. But different mechanisms of HIV-1 resistance to bnAbs prevent robust application of bnAbs for therapeutic and preventive interventions. RESULTS: Here we report the development of a new database that provides data and computational tools to aid the discovery of resistant features and may assist in analysis of HIV-1 resistance to bnAbs. Bioinformatic tools allow identification of specific patterns in Env sequences of resistant strains and development of strategies to elucidate the mechanisms of HIV-1 escape; comparison of resistant and sensitive HIV-1 strains for each bnAb; identification of resistance and sensitivity signatures associated with specific bnAbs or groups of bnAbs; and visualization of antibody pairs on cross-sensitivity plots. The database has been designed with a particular focus on user-friendly and interactive interface. Our database is a valuable resource for the scientific community and provides opportunities to investigate patterns of HIV-1 resistance and to develop new approaches aimed to overcome HIV-1 resistance to bnAbs. AVAILABILITY AND IMPLEMENTATION: HIResist is freely available at https://hiresist.ahc.umn.edu/.
Milind Misra, Jeffy Jeffy, Charis Liao, Stephanie Pickthorn, Kshitij Wagh, Alon Herschhorn
Bioinform.1
2008 Genome scale enzyme-metabolite and drug-target interaction predictions using the signature molecular descriptor
abstract
Abstract Motivation: Identifying protein enzymatic or pharmacological activities are important areas of research in biology and chemistry. Biological and chemical databases are increasingly being populated with linkages between protein sequences and chemical structures. There is now sufficient information to apply machine-learning techniques to predict interactions between chemicals and proteins at a genome scale. Current machine-learning techniques use as input either protein sequences and structures or chemical information. We propose here a method to infer protein–chemical interactions using heterogeneous input consisting of both protein sequence and chemical information. Results: Our method relies on expressing proteins and chemicals with a common cheminformatics representation. We demonstrate our approach by predicting whether proteins can catalyze reactions not present in training sets. We also predict whether a given drug can bind a target, in the absence of prior binding information for that drug and target. Such predictions cannot be made with current machine-learning techniques requiring binding information for individual reactions or individual targets. Availability and Contact: For questions, paper reprints, please contact Jean-Loup Faulon at [email protected]. Additional information on the signature molecular descriptor and codes can be downloaded at: http://www.cs.sandia.gov/~jfaulon/publication-signature.html Supplementary information: Supplementary data are available at Bioinformatics online.
Jean-Loup Faulon, Milind Misra, Shawn Martin, Kenneth L. Sale, Rajat Sapra
Bioinform.2
2007 Flavitrack: an annotated database of flavivirus sequences
abstract
MOTIVATION: Properly annotated sequence data for flaviviruses, which cause diseases, such as tick-borne encephalitis (TBE), dengue fever (DF), West Nile (WN) and yellow fever (YF), can aid in the design of antiviral drugs and vaccines to prevent their spread. Flavitrack was designed to help identify conserved sequence motifs, interpret mutational and structural data and track evolution of phenotypic properties. SUMMARY: Flavitrack contains over 590 complete flavivirus genome/protein sequences and information on known mutations and literature references. Each sequence has been manually annotated according to its date and place of isolation, phenotype and lethality. Internal tools are provided to rapidly determine relationships between viruses in Flavitrack and sequences provided by the user.
Milind Misra, Catherine H. Schein
Bioinform.1